We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 546

Tech interests praise USPTO director nomination
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

According to a news source, technology industry interests have lauded President Barack Obama's (D) choice for U.S. Patent and Trademark Office


Biotech boards dominated by men
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A Liftstream analysis reportedly shows that the average Board of Directors in the biotechnology sphere is roughly 90 percent male and more than half


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting


Third Circuit revives shareholder suit over dissolved biotech company
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A divided Third Circuit Court of Appeals panel has reversed a district court ruling dismissing a shareholder's lawsuit against individuals and a


Nagoya genetic resources protocol enters into force
  • Shook Hardy & Bacon LLP
  • Global, USA
  • October 30 2014

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization entered into force


Ninth Circuit okays pharma waste disposal ordinance
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The Ninth Circuit Court of Appeals has upheld the validity of an Alameda County ordinance that requires prescription drug producers that sell brand


D.C. Circuit upholds civil conviction in manufacture of stem cell therapy
  • Shook Hardy & Bacon LLP
  • USA
  • February 13 2014

The D.C. Circuit Court of Appeals has affirmed a lower court's grant of the government's motion for summary judgment and the imposition of a


Class action filed against 23andMe, Inc. over efficacy of home DNA test kits
  • Shook Hardy & Bacon LLP
  • USA
  • January 30 2014

A New Mexico resident has filed a putative nationwide class action against 23andMe, Inc., alleging that claims for its DNA Collection Kits&mdash


USPTO to host roundtable on harmonization of substantive patent law
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2014

The U.S. Patent and Trademark Office (USPTO) will host a November 19, 2014, roundtable in Alexandria, Virginia, on the international harmonization of


Growth of ‘bio-factories’ expected to increase
  • Shook Hardy & Bacon LLP
  • USA
  • October 31 2013

According to The Washington Post, annual revenue from companies that manufacture industrial chemicals through synthetic biology is approximately $1.5